Australian Consumer Services Stock News

ASX:WBT
ASX:WBTSemiconductor

Weebit Nano (ASX:WBT) Shares Confront Deepening Losses Despite Revenue Progress

Weebit Nano shareholders have watched the stock slide in recent months, with the price now at A$3.75 after a tough 90 days. Today's full year numbers keep that pressure squarely on profitability. Revenue for FY 2026 remains modest at A$15.28m on a trailing twelve month basis, while losses from continuing operations widened to A$54.90m. For a pre revenue scale semiconductor player, this earnings release focuses on how long the company can fund that loss profile and how investors balance the...
ASX:SSG
ASX:SSGSpecialty Retail

Shaver Shop (ASX:SSG) Shares Reflect Record Sales But Flat Profit

Shaver Shop Group went into this result priced like a value play, with the stock at A$1.41 and a P/E of 12.5x that sat below peer and industry averages. The headline from the numbers is not a growth surge. It is a tension between record sales of A$225.1m and record gross margin of 46.3% on one side and essentially flat net profit after tax of A$14.8m on the other. That mix sets up a classic sentiment test. Traders focused only on headline records might cheer, while investors watching a 90%...
ASX:ACW
ASX:ACWBiotechs

Actinogen Medical (ASX:ACW) Shares Face Funding Pressure As Losses Deepen

Actinogen Medical entered this earnings season as a high risk biotech stock with a thin cash cushion and an unprofitable track record. The share price now trades at A$0.044 after a weak 7 day run and a stronger 3 month climb. The headline from this FY 2026 release is the pressure on the balance sheet. Management reported a loss of A$15.4 million over the trailing 12 months with no clear profitability in view and less than one year of cash runway. Concerned by Actinogen Medical's cash runway...
ASX:SHL
ASX:SHLHealthcare

Why Sonic Healthcare (ASX:SHL) Is Back In The Spotlight

Why Sonic Healthcare’s latest earnings and dividend matter now Sonic Healthcare (ASX:SHL) has drawn fresh attention after releasing full year 2026 results, confirming higher revenue and net income than a year earlier, alongside a declared dividend for the June half. Sonic Healthcare’s share price has softened in the short term, with a 7 day share price return of 4.93% and a 30 day share price return of 11.8% down to A$20.04. The 1 year total shareholder return has declined 12.74%, pointing to...
ASX:IMB
ASX:IMBCommercial Services

Intelligent Monitoring Group (ASX:IMB) Shares Eye Profit Turn As Debt Looms

Intelligent Monitoring Group closed at A$0.645 today, barely moved over the past week, even as the latest result quietly shifted the story. The headline is simple. This security and monitoring stock has flipped from a loss in the first half to a full year in the black, with A$3.43m of second half net income and operating cash roughly doubling to around A$22m. The short term share price reaction looks muted. The long term question now is whether this early turn in profitability and cash...
ASX:HZN
ASX:HZNOil and Gas

Horizon Oil (ASX:HZN) Shares Eye Cash Strength As Earnings Slip

Horizon Oil entered this result period with the stock down over the past week and quarter, yet still on a punchy 24.2x trailing P/E. The market clearly treated the shares as a higher multiple oil and gas story, then watched a small stock trading at A$0.22 deliver a year where free cash flow and profitability became the headline. The key factor this time is the balance sheet and cash engine. Horizon Oil finished FY26 with US$37.4m in cash, modest net debt of US$11.3m and free cash flow of...
ASX:HVN
ASX:HVNMultiline Retail

Harvey Norman (ASX:HVN) Shares Signal Value While Margins Keep Tightening

Harvey Norman Holdings stock has been grinding lower for weeks, with the share price down about 12% over the past month and closing at A$4.42. Yet the fresh earnings story is less about a collapsing business and more about a slow squeeze on profitability. Revenue over the last twelve months sits above A$3.0b, but net profit margin has edged back to 17.3% and trailing earnings have softened. The immediate question for you now is simple: Is this a value opportunity on a low P/E, or a warning...
ASX:STO
ASX:STOOil and Gas

Where Does Santos (ASX:STO) Valuation Sit After Half Year Results And Dividend Confirmation?

Santos (ASX:STO) has released half year results showing net income of US$355 million and a lower earnings per share figure than a year earlier. The company also affirmed an interim dividend of US$0.116 per share. At a share price of A$8.12, Santos has seen a 32.03% year to date share price return, while the 1 year total shareholder return of 8.20% and 5 year total shareholder return of 64.47% point to gains built over a longer period. Recent dividend announcements and the half year earnings...
ASX:GDG
ASX:GDGInsurance

Generation Development Group (ASX:GDG) Shares Drift As FUM Strength Meets Thin Margins

Generation Development Group came into this result with a stock that has been sliding, down about 23% over the past month and about 22% over three months, and trading on a rich trailing P/E of 40.1x. That set a high bar. The headline from FY 2026 is clear. Underlying profit stepped up, with group net income of A$25.1m in the second half and A$6.9m in the first half, backed by A$583.7m in trailing twelve month revenue. The market is now weighing those earnings against an elevated valuation and...
ASX:BAP
ASX:BAPRetail Distributors

Bapcor (ASX:BAP) Shares Chase A Turnaround Through A Deepening Loss

Bapcor walked into this result with a stock that had already bounced hard, up more than 65% over the past three months to about A$0.705. Yet the headline numbers are still all about repair rather than reward. The market is pricing a turnaround story. The earnings print shows a very different reality. Revenue for FY26 landed at about A$1.924b while the company reported a statutory loss of A$431.6m driven largely by impairment charges. For you as an investor, the key angle is profit pressure...
ASX:OCL
ASX:OCLSoftware

Objective (ASX:OCL) Shares Face Contract Churn After 35% Slide

Objective shareholders came into this result already on the back foot, with the stock down around 35% over the past three months and closing at A$6.80 ahead of digesting the full year story. The earnings headline is not about a blow up in profit. It is about how the market squares that slump in sentiment with a software company reporting A$134.7m in revenue, A$37.2m in net profit and an adjusted EBITDA margin near 39%. The key question now is whether that earnings power and a fully franked...
ASX:AMI
ASX:AMIMetals and Mining

Aurelia Metals (ASX:AMI) Shares Rally On Profit Surge And Execution Questions

Aurelia Metals walked into this result already on a tear, with the stock up about 48% over the past month and 55% over three months. The market has been pricing in a turnaround story. The earnings print delivered headline fuel for that optimism, with net profit after tax of A$82.7m and earnings per share of A$0.0488 on A$480.2m of revenue. The key question now is whether the strong margin profile and high non cash earnings mix justify the recent re rating, or if short term enthusiasm has run...
ASX:RHC
ASX:RHCHealthcare

Ramsay Health Care (ASX:RHC): Is Profitability Rebound Recasting Its Core Risk-Reward Profile?

Ramsay Health Care Limited recently reported full-year results to 30 June 2026, with sales rising to A$18.58 billion, revenue to A$18.71 billion, and net income increasing to A$329.2 million, lifting earnings per share from continuing operations to around A$1.36. The results highlight how efficiency measures and cost management, alongside EBIT growth in all regions and positive net cash flow, have reshaped Ramsay’s profitability profile over the past year. We’ll now explore how this rebound...
ASX:DUG
ASX:DUGSoftware

DUG Technology (ASX:DUG) Shares Face Pressure From Debt And Rich Valuation

DUG Technology stock has been hit hard in recent months, down about 33% over 90 days and about 21% over 30 days, even after closing at A$1.59 following its full year 2026 result. The headline from these earnings is not the top line itself. It is the pressure around what that revenue and profit now have to support. The company is freshly profitable on a trailing basis and carrying a high P/E multiple near 85x against a peer group closer to 22x. At the same time, net debt sits around US$13m...
ASX:ELV
ASX:ELVMetals and Mining

Elevra Lithium (ASX:ELV) Shares Drift Lower Despite Profit Rebound

Elevra Lithium closed at A$8.30 after a choppy week that left the stock down about 9% over seven days and still deep in the red over three months. The share price looks tired. The earnings do not. The headline this season is a clean swing into profit, with underlying group EBITDA moving into the black and reported profit supported by a large impairment reversal at the flagship North American Lithium operation. In the short term, traders are focused on the drawdown from the recent peak. Long...
ASX:MYX
ASX:MYXPharmaceuticals

Are Mayne Pharma Group (ASX:MYX) Shares Undervalued As Earnings Contract?

Mayne Pharma Group shares have slipped over the past week even after closing at A$3.01, leaving short term traders unimpressed. Yet the latest full year numbers tell a tougher story than the headline share price suggests. Revenue for FY26 came in at A$383.7m with underlying earnings before interest, tax, depreciation and amortisation of A$34.2m, both weaker than last year. The real pivot is in the outlook. Consensus points to earnings decline over the next three years, even as the stock...
ASX:WDS
ASX:WDSOil and Gas

Woodside Energy Group (ASX:WDS), Why Is Its Latest Update Drawing Attention?

Woodside Energy Group (ASX:WDS) has drawn fresh attention after reporting a 7% rise in half year net profit, lifting its interim dividend and outlining a shift away from earlier clean energy investment targets. At a latest share price of A$32.27, Woodside Energy Group has cooled off in the very short term, with a 7 day share price return down 4.47%. However, the year to date share price return of 36.39% and 5 year total shareholder return of 131.35% still indicate strong longer term...
ASX:CBO
ASX:CBOFood

Cobram Estate Olives (ASX:CBO) Shares Reflect Revenue Growth And Profit Compression

Cobram Estate Olives stock closed at A$2.81 after a rough run where the share price has fallen about 32% over three months. Yet the headline from these earnings is not the share price. It is the squeeze on profitability after a heavy year of investment and acquisition. Normalized EBITDA of A$61.4m sits against a much slimmer A$13.0m in normalized earnings before tax once one off items tied to the California Olive Ranch deal are counted. For anyone looking beyond today’s price reaction, the...
ASX:NXT
ASX:NXTIT

NEXTDC (ASX:NXT) Shares Face Profit Questions After Valuation Stays Rich

NEXTDC just turned a headline profit year, yet the stock closed at A$13.87 with only a modest single digit gain over the past week and a small rise over the month after the result. That is a muted reaction for a data centre operator now reporting A$496.5m in trailing twelve month revenue and A$82.1m in earnings from continuing operations. The expectation gap sits in the valuation. NEXTDC trades on a trailing P/E near 128x. The market is already paying up for growth. The key question after...
ASX:MLX
ASX:MLXMetals and Mining

Metals X (ASX:MLX) Shares Reflect Strong Growth And Thinning Margins

Metals X walked into this half with a value stock label and a trailing P/E of 10.9x that sat below both peers and the broader Australian market. The share price closed at A$1.915 on 28 August, capping a strong 30 day run. However, the market now has to absorb a set of results built on very rich profitability. Net profit margin over the last 12 months sits at 45.5%, while trailing twelve month earnings from continuing operations reached A$155.6 million. The key question for you is how...
ASX:360
ASX:360Software

Is Life360’s Pet Ecosystem Expansion Reshaping The Investment Case For Life360 (ASX:360)?

In August 2026, Life360 expanded its pet-focused ecosystem with new in-app Care and Connection features plus a QR code Life360 Pet Tag, building on its recently launched Pet GPS tracker to help families coordinate pet care and reunite more quickly with lost animals across multiple global markets. By extending its “family safety” platform to pets through recurring care routines, Zoomies Alerts, and affordable hardware bundles, Life360 is broadening how deeply it can embed into everyday...